The Promise of Janus Kinase Inhibitors

Jul 26, 2021, 09:12 PM
Headliner
Share
Subscribe
In this Derm Discussions, Brett King, MD, PhD, joins Brad Glick, DO, to discuss the potential of the JAK inhibitor class for dermatology. 
Share
Subscribe
Next
Safety of JAK Inhibitors
Top episodes
Autoimmune Hepatitis at ACG 2023, with Gina Choi, MD
by HCPLive Podcasts
What We Know About the Omicron Variant
by HCPLive Podcasts
Cardiology in 2019 with Deepak Bhatt, MD, MPH
by HCPLive Podcasts